Insights from prospective multi-omic profiling of lymphocytes in resected lung cancer

Ann Oncol. 2022 Jan;33(1):4-5. doi: 10.1016/j.annonc.2021.10.013. Epub 2021 Oct 27.

Authors

A Chow¹, M D Hellmann²

Affiliations

¹ Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA; Weill Cornell Medical College, New York, USA. Electronic address: chowa1@mskcc.org.
² Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA; Weill Cornell Medical College, New York, USA; Parker Institute for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center, New York, USA.

PMID: 34715315
DOI: 10.1016/j.annonc.2021.10.013

No abstract available

Publication types

Editorial
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Genomics*
Humans
Lung Neoplasms* / genetics
Lung Neoplasms* / surgery
Lymphocytes
Prospective Studies

Grants and funding